DISCORDANCE BETWEEN BODY MASS INDEX AND ANTHROPOMETRIC MEASUREMENTS AMONG HIV-1-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY AND WITH LIPOATROPHY/LIPOHYPERTROPHY SYNDROME

Carregando...
Imagem de Miniatura
Citações na Scopus
17
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
INST MEDICINA TROPICAL SAO PAULO
Citação
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, v.57, n.2, p.105-110, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: Highly Active Antiretroviral Therapy (HAART) has improved and extended the lives of thousands of people living with HIV/AIDS around the world. However, this treatment can lead to the development of adverse reactions such as lipoatrophy/lipohypertrophy syndrome (LLS) and its associated risks. Objective: This study was designed to assess the prevalence of self-reported lipodystrophy and nutritional status by anthropometric measurements in patients with HIV/AIDS. Methods: An observational study of 227 adult patients in the Secondary Immunodeficiencies Outpatient Department of Dermatology, Hospital das Clinicas, Faculty of Medicine, University of Sao Paulo (3002 ADEE-HCFMUSP). The sample was divided into three groups; Group 1 = 92 patients on HAART and with self-reported lipodystrophy, Group 2 = 70 patients on HAART without self-reported lipodystrophy and Group 3 = 65 patients not taking HAART. The nutritional status of individuals in the study sample was determined by body mass index (BMI) and percentage of body fat (% BF). The cardiovascular risk and diseases associated with abdominal obesity were determined by waist/hip ratio (WHR) and waist circumference (WC). Results: The prevalence of self-reported lipoatrophy/lipohypertrophy syndrome was 33% among women and 59% among men. Anthropometry showed depletion of fat mass in the evaluation of the triceps (TSF) in the treatment groups with HAART and was statistically independent of gender; for men p = 0.001, and for women p = 0.007. Similar results were found in the measurement of skin folds of the upper and lower body (p = 0.001 and p = 0.003 respectively). In assessing the nutritional status of groups by BMI and % BF, excess weight and body fat were more prevalent among women compared to men (p = 0.726). The WHR and WC revealed risks for cardiovascular and other diseases associated with abdominal obesity for women on HAART and with self-reported LLS (p = 0.005) and (p = 0.011). Conclusions: Anthropometric measurements were useful in the confirmation of the prevalence of LLS. BMI alone does not appear to be a good parameter for assessing the nutritional status of HIV-infected patients on HAART and with LLS. Other anthropometric measurements are needed to evaluate patients with the lipoatrophy/lipohypertrophy syndrome.
Palavras-chave
HIV, Lipoatrophy/lipohypertrophy syndrome, Nutrition, Anthropometry, Brazil
Referências
  1. Almeida LB, 2006, J BRAS AIDS, V7, P1
  2. FIELDSGARDNER C, 1994, J AM DIET ASSOC, V94, P1042
  3. Baril Jean-Guy, 2005, Can J Infect Dis Med Microbiol, V16, P233
  4. Barsotti V, 2007, REV FAC CIENC MED SO, V9, P4
  5. BLACKBURN GL, 1979, MED CLIN N AM, V63, P1103
  6. Calvo M, 2014, CURR OPIN HIV AIDS, V9, P332, DOI 10.1097/COH.0000000000000075
  7. Carr A, 2000, CLIN INFECT DIS, V30, pS135, DOI 10.1086/313854
  8. Ceccato MGB, 2011, BRAZ J MED BIOL RES, V44, P1177, DOI [10.1590/S0100-879X2011007500129, 10.1590/S0100-879X2011001100015]
  9. Christeff N, 1999, AIDS, V13, P2251, DOI 10.1097/00002030-199911120-00007
  10. COMPCORP SISTEMAS. V Corp Bioimpedancia, 1998, PROGR AV CORP BIOIMP
  11. DEURENBERG P, 1988, EUR J CLIN NUTR, V42, P1017
  12. DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060
  13. Dutra CDT, 2008, REV NUTR, V21, P439, DOI 10.1590/S1415-52732008000400008
  14. Franca AP, 2007, THESIS U SAO PAULO
  15. Frisancho AR, 1990, ANTHROPOMETRIC STAND
  16. Gallagher D, 2000, AM J CLIN NUTR, V72, P694
  17. Galli M, 2002, ARCH INTERN MED, V162, P2621, DOI 10.1001/archinte.162.22.2621
  18. Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811
  19. Guaraldi G, 2008, AIDS PATIENT CARE ST, V22, P577, DOI 10.1089/apc.2007.0173
  20. Hadigan C, 2001, CLIN INFECT DIS, V32, P130, DOI 10.1086/317541
  21. HARRIS TB, 1993, AM J EPIDEMIOL, V137, P1318
  22. Heath KV, 2002, INT J EPIDEMIOL, V31, P1016, DOI 10.1093/ije/31.5.1016
  23. Heymsfield SB, 2002, TRATADO NUTR MODERNA, V9, P965
  24. Heyward VH, 2000, AVALIACAO COMPOSICAO
  25. Jaime PC, 2004, REV BRAS EPIDEMIOL, V7, P65
  26. Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48
  27. Lichtenstein KA, 2005, JAIDS-J ACQ IMM DEF, V39, P395, DOI 10.1097/01.qai.0000167478.28051.3a
  28. McDowel MA, 2005, ANTHROPOMETRIC REFEN
  29. Minitab Inc, 2007, MINITAB 15
  30. Monteiro CA, 2000, VELHOS NOVOS MALES S, P421
  31. Montessori V, 2004, CAN MED ASSOC J, V170, P229
  32. Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301
  33. Rexrode KM, 1997, JAMA-J AM MED ASSOC, V277, P1539, DOI 10.1001/jama.277.19.1539
  34. Samaras K, 2007, DIABETES CARE, V30, P113, DOI 10.2337/dc06-1075
  35. Sanches RS, 2008, THESIS U SAO PAULO R
  36. Signorini DJHP, 2012, REV ASSOC MED BRAS, V58, P70, DOI 10.1590/S0104-42302012000100017
  37. World Health Organization, 2000, WHO TECHN REP SER
  38. World Health Organization, GLOB AIDS RESP PROGR
  39. Zhu SK, 2003, AM J CLIN NUTR, V78, P228